By DiSilvestro RA, Goodman J., Dy E., LaValle G. Breast Cancer Research and Treatment 89 (2005): 251–255. Soy isoflavones have been given considerable attention in regard to breast cancer, both for prevention and for increasing risk. Soy isoflavone antioxidant effects may help prevent breast cancer re-occurrence, but isoflavone estrogen-like actions may increase breast cancer risk. [...]
Soy isoflavones for the relief of climacteric symptoms in women with breast cancer or in whom estrogen replacement therapy is not recommended
By Giorgio Secreto et al, Maturitas 47 (2004): 11-20 HRT may be contraindicated or not advisable in postmenopausal women who have or had breast cancer, women with a family history for breast cancer, or women who stopped HRT after 5 years of treatment. Soy isoflavones may be a natural alternative for them. Verifying the efficacy [...]

The right composition: US study documents safety and efficacy of SoyLife® from Frutarom for osteoporosis prevention
Isoflavones are well known for their ability to treat postmenopausal symptoms, especially in the prevention of osteoporosis. Manufacturers who want to create supplements with a bone health indication can choose from a wide variety of different isoflavone substances, but there are huge differences between the individual ingredients – a fact that is less well known. [...]

Soy Germ Isoflavones Found to Be Safe
Summary: Focusing on the effects of soy isoflavones on osteoporosis prevention, the major secondary outcome measured in the OPUS study was safety . No increased risk was observed for breast cancer or endometrial cancer due to supplementation. The Osteoporosis Prevention Using Soy (OPUS) intervention study, funded by the United States Department of Agriculture (USDA), has [...]
OPUS finds soy isovlavones safe
WÄDENSWIL, Switzerland—Countering prior theories soy isoflavone supplementation can contribute to increased breast cancer risk, new findings from the Osteoporosis Prevention Using Soy (OPUS) intervention study, funded by the USDA, has confirmed that long-term supplementation with soy hypocotyl isoflavones does not cause adverse effects. The findings wee published in the American Journal of Clinical Nutrition (2011; [...]
Soy germ isoflavenes found to be safe
Long-term clinical study delivers convincing results on the safety of soy hypocotyl isoflavones in menopausal women. Wädenswil/Switzerland, February 2011 The Osteoporosis Prevention Using Soy (OPUS) intervention study, funded by the United States Department of Agriculture (USDA), has confirmed that regular supplementation with soy hypocotyl isoflavones over long periods does not cause adverse effects. It can [...]

Soy germ isoflavones: proven safety
Abstract: A long-term study shows that soy isoflavones hypocotyl for women in the Menopause are safe. Frutarom is relieved. Title: alimentaonline.ch Issue: 11 February 2011 Country: United States Page: online publication Circulation: On behalf of the U.S. Department of Agriculture (USDA) conducting the OPUS (Osteoporosis Prevention Using Soy) intervention study, results showed that regular [...]
Recent Posts
- Safety aspects of soyfoods and soy isoflavones in men
- Safety of Frutarom`s daidzein rich SoyLife products
- SoyLife Overview
- Soylife, Calcium and Vit D in the prevention of osteoporosis – OPUS study 2004–2007
- SoyLife® Extra
- Soy isoflavone supplementation enhances spatial working memory in Men
- Safety evaluation of SoyLife
- Various doses of soy isoflavones do not modify mammographic density in postmenopausal women
- Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors
- Estrogenic activity of glycitein, a soy isoflavone

